# A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

> **NCT06679140** · PHASE3 · RECRUITING · sponsor: **Pfizer** · enrollment: 2330 (estimated)

## Conditions studied

- COVID-19 SARS-CoV-2 Infection

## Interventions

- **DRUG:** ibuzatrelvir
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06679140
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-08
- **Primary completion:** 2027-10-03
- **Final completion:** 2028-03-02
- **Target enrollment:** 2330 (ESTIMATED)
- **Last updated:** 2026-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06679140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06679140, "A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT06679140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*